Vancomycin Articles

Vancomycin continues to dominate MRSA treatment with up to 76% of US specialists using the drug; Study

25 May 2011

ViroPharma told Vanocin not focus of OGD meeting by FDA

14 July 2008

ViroPharma acquires US Vancocin brand

25 October 2004

Shionogi profits up on plan, sales decline

23 August 2004

Showing 1-4 of 4 articles

Go to beginningPrevious
  • 1
NextGo to end